LATE-NC in Alzheimer's disease: Molecular aspects and synergies

被引:5
|
作者
Tome, Sandra O. [1 ,2 ]
Gawor, Klara [1 ,2 ]
Thal, Dietmar Rudolf [1 ,2 ,3 ]
机构
[1] Katholieke Univ Leuven, Dept Imaging & Pathol, Lab Neuropathol, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium
关键词
Alzheimer's disease; LATE-NC; tau; TDP-43; DNA-BINDING PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; HIPPOCAMPAL SCLEROSIS; TDP-43; PATHOLOGY; COGNITIVE DECLINE; BRAIN-REGIONS; DEMENTIA; TAU; ENCEPHALOPATHY; IMMUNOREACTIVITY;
D O I
10.1111/bpa.13213
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD) is classically characterized by senile plaques and neurofibrillary tangles (NFTs). However, multiple copathologies can be observed in the AD brain and contribute to the development of cognitive decline. Limbic-predominant age-related TDP-43 encephalopathy neuropathological changes (LATE-NC) accumulates in the majority of AD cases and leads to more severe cognitive decline compared with AD pathology alone. In this review, we focus on the synergistic relationship between LATE-NC and tau in AD, highlighting the aggravating role of TDP-43 aggregates on tau pathogenesis and its impact on the clinical picture and therapeutic strategies. Additionally, we discuss to what extent the molecular patterns of LATE-NC in AD differ from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) neuropathological changes. Thus, we highlight the importance of tau and TDP-43 synergies for subtyping AD patients, which may respond differently to therapeutic interventions depending on the presence of comorbid LATE-NC.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
    Kandimalla, Ramesh J.
    Anand, R.
    Veeramanikandan, R.
    Wani, Willayat Yousuf
    Prabhakar, Sudesh
    Grover, Vinod K.
    Bharadwaj, Neerja
    Jain, Kajal
    Gill, Kiran Dip
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (04) : 340 - 348
  • [42] LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry
    Katsumata, Yuriko
    Alzheimers Dis Genetics Consortium
    Fardo, David W.
    Shade, Lincoln M. P.
    Nelson, Peter T.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (09) : 760 - 768
  • [43] Alzheimer's Disease in the Down Syndrome: An Overview of Genetics and Molecular Aspects
    Gomes, Fabiana de C.
    Mattos, Marlon F.
    Goloni-Bertollo, Eny M.
    Pavarino, Erika C.
    NEUROLOGY INDIA, 2021, 69 (01) : 32 - 41
  • [44] When Alzheimer's is LATE: Why Does it Matter?
    Nelson, Peter T.
    Schneider, Julie A.
    Jicha, Gregory A.
    Duong, Michael Tran
    Wolk, David A.
    ANNALS OF NEUROLOGY, 2023, 94 (02) : 211 - 222
  • [45] Staging TDP-43 pathology in Alzheimer's disease
    Josephs, Keith A.
    Murray, Melissa E.
    Whitwell, Jennifer L.
    Parisi, Joseph E.
    Petrucelli, Leonard
    Jack, Clifford R.
    Petersen, Ronald C.
    Dickson, Dennis W.
    ACTA NEUROPATHOLOGICA, 2014, 127 (03) : 441 - 450
  • [46] Tau and Alzheimer’s Disease: Molecular Mechanisms and Treatment Approaches
    Allison B. Reiss
    Dalia Muhieddine
    Ariel Z. De Leon
    Iryna Voloshyna
    Irving H. Gomolin
    Aaron Pinkhasov
    SN Comprehensive Clinical Medicine, 4 (1)
  • [47] Analytical aspects of molecular Alzheimer's disease biomarkers
    Andreasson, Ulf
    Vanmechelen, Eugeen
    Shaw, Leslie M.
    Zetterberg, Henrik
    Vanderstichele, Hugo
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 377 - 389
  • [48] Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease
    Cai, Qian
    Tammineni, Prasad
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1087 - 1103
  • [49] Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer's disease
    Davidson, Yvonne S.
    Robinson, Andrew C.
    Snowden, Julie S.
    Mann, David M. A.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2013, 1
  • [50] Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes
    Schaeverbeke, Jolien
    Tome, Sandra O.
    Ronisz, Alicja
    Ospitalieri, Simona
    von Arnim, Christine A. F.
    Otto, Markus
    Vandenberghe, Rik
    Thal, Dietmar Rudolf
    ALZHEIMERS & DEMENTIA, 2023, 19 (04) : 1440 - 1451